FDA fiscal year (FY) 2018 financial management evaluation for human drug user fees
Ended Awarded Last action
- Contract number
- HHSF223201810033W
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,526,446
Award facts
- Opportunity
-
- RFPCMS20110021 Solicitation number
- Centers for Medicare & Medicaid Services sponsored Federally Funded Research and Development Center Award Notice · Posted Mar 17, 2011
- Contract value 100% obligated
- $2,526,446.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West McLean, VA 22102, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$106,692 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,633,138 |
About this award
The Food and Drug Administration awarded a delivery order against an unspecified contract vehicle to The Mitre Corporation for $2,526,446.46 to conduct a thorough evaluation of FDA's current financial management practices for its Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Act programs. The goal is to provide recommendations ensuring FDA's user fee program financial management is consistent with best practices. Mitre will partner with subcontractor Grant Thornton LLP on the evaluation, which will result in a publicly releasable report. No set-aside designation was utilized for this order to assess and advise on improving FDA's management of substantial user fee programs funding medical product review.
Quick answers
Who was awarded contract HHSF223201810033W?
HHSF223201810033W was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on February 8, 2018.
How much is contract HHSF223201810033W worth?
The government has obligated $2,526,446 on HHSF223201810033W.
Is contract HHSF223201810033W an order under another contract?
Yes. HHSF223201810033W is a delivery order under HHSM500201200008I, an indefinite delivery contract.
Was contract HHSF223201810033W competed?
The extent of competition for HHSF223201810033W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award